DRG’s new Physician Forum study provides a market assessment of the emerging renal denervation technology for device-based treatment of hypertension. This study surveyed 146 physicians—including general cardiologists, hypertension specialists, interventional cardiologists, and interventional radiologists in the US and Europe—who are performing renal denervation procedures, will be performing these procedures, or will be referring patients for renal denervation treatment. Respondents identified current procedure usage, future procedure opportunity, potential procedure drivers and limiters, and key device characteristics of renal denervation devices.
What Questions Will Physician Forum Help You Answer?
Key Sections: The following is an overview of the structure of the publication.
Methodology: This survey was designed by DRG analysts with expertise in researching and analyzing trends and technologies in the cardiovascular market.